95.36
Lemaitre Vascular Inc stock is traded at $95.36, with a volume of 93,841.
It is up +0.10% in the last 24 hours and up +15.68% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$95.27
Open:
$96
24h Volume:
93,841
Relative Volume:
0.58
Market Cap:
$2.16B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
52.11
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
-4.95%
1M Performance:
+15.68%
6M Performance:
-4.55%
1Y Performance:
+7.61%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LMAT
Lemaitre Vascular Inc
|
95.36 | 2.16B | 213.03M | 41.32M | 33.49M | 1.83 |
![]()
ISRG
Intuitive Surgical Inc
|
473.30 | 169.86B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
192.98 | 54.82B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
274.51 | 40.32B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
ALC
Alcon Inc
|
79.81 | 39.28B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
WST
West Pharmaceutical Services Inc
|
246.95 | 17.65B | 2.96B | 487.70M | 344.00M | 6.68 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
Aug-02-24 | Resumed | Lake Street | Buy |
May-31-24 | Resumed | ROTH MKM | Buy |
Apr-26-24 | Upgrade | Stifel | Hold → Buy |
Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-06-23 | Initiated | Oppenheimer | Outperform |
Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Sep-16-21 | Initiated | Jefferies | Buy |
Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
Jul-25-19 | Reiterated | Barrington Research | Outperform |
Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
Jun-08-18 | Resumed | ROTH Capital | Buy |
Apr-26-18 | Downgrade | Stifel | Buy → Hold |
Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
Mar-21-17 | Initiated | First Analysis Sec | Overweight |
Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
Jul-28-16 | Reiterated | Barrington Research | Outperform |
Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Technical signs of recovery in LeMaitre Vascular Inc.Weekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
Does LeMaitre Vascular Inc. fit your quant trading modelJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Statistical indicators supporting LeMaitre Vascular Inc.’s strengthJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - Newser
Nuveen LLC Takes Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
How to use Fibonacci retracement on LeMaitre Vascular Inc.Market Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
LeMaitre Vascular Inc. stock daily chart insightsJuly 2025 Spike Watch & Weekly Top Performers Watchlists - Newser
Ranking LeMaitre Vascular Inc. among high performing stocks via tools2025 Year in Review & Risk Managed Investment Entry Signals - Newser
Will LeMaitre Vascular Inc. price bounce be sustainableJuly 2025 Institutional & Growth Focused Entry Reports - Newser
Will LeMaitre Vascular Inc. continue its uptrendStop Loss & Expert Verified Movement Alerts - Newser
Chart based analysis of LeMaitre Vascular Inc. trendsDividend Hike & Safe Capital Growth Stock Tips - Newser
LeMaitre Vascular, Inc. $LMAT Stock Holdings Lifted by Credit Agricole S A - MarketBeat
AlphaQuest LLC Grows Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Live market analysis of LeMaitre Vascular Inc.July 2025 Setups & Fast Entry Momentum Trade Alerts - Newser
Synovus Financial Corp Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Historical volatility pattern of LeMaitre Vascular Inc. visualized2025 Momentum Check & Fast Gain Stock Tips - Newser
Algert Global LLC Grows Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Key External Factors That Drive LeMaitre Vascular Inc. Stock Price MovementsWeekly Volume Report & Entry and Exit Point Strategies - Newser
LeMaitre Vascular Inc. Matches Institutional Buying Filter getLinesFromResByArray error: size == 0 - newsyoung.net
Comerica Bank Increases Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
What to expect from LeMaitre Vascular Inc. in the next 30 daysTrade Analysis Report & Low Drawdown Trading Strategies - Newser
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):